Interrogation of Genetic Dependencies in Renal Cell Carcinomas.
Description preview
We have established a Cas9-Cas12a CHyMErA-based combinatorial CRISPR screening platform in patient-derived renal cell carcinoma (RCC) cell lines and confirmed robust nuclease expression and genome editing efficiency. Leveraging a genome-wide CRISPR knockout library, we conducted systematic screens across diverse environmental and genetic RCC…
Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click